Credits Available: 4.75 hours of AMA PRA Category 1 Credit™ with ABIM MOC

Description: This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging clinical trial data to optimize patient outcomes.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Oncology, Hematology/Oncology

Ludmila Svoboda

Dana-Farber Cancer Institute
Nurse Director Cancer Care Equity Program

Hi! My name is Ludmila and I am so excited to be here with all of you. I've worked in oncology for my entire career and have practiced in a great variety of settings from Manhattan to New Mexico, Haiti and Boston. My experience spans across solid tumor and liquid cancers and this breadth of experience has brought me to oncology education. I currently am the nurse director for the Cancer Care Equity Program at Dana-Farber Cancer Institute in Boston, a role that has allowed me to combine my love for oncology with my commitment to social justice and the elimination of disparities in access to cancer care for all, particularly historically marginalized groups.